文献速递精神分裂症与精神病性障碍

多巴胺D3受体与dysbindin-1的基因上位性交互调控小鼠与人类高级认知功能

The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.
PubMed 文献 · Mol Psychiatry · 2019-09-06

该研究揭示多巴胺D3受体(D3)与dysbindin-1(Dys)功能遗传变异间的上位性交互:在精神分裂症患者与基因修饰小鼠中,D3与Dys功能同步降低均与执行功能和工作记忆能力改善相关。该交互导致前额叶皮层而非纹状体D2/D3失衡、偏向D2信号增强,对PANSS评分无上位效应,提示前额叶D2/D3失衡可作为患者分层与促认知治疗靶点。

要点

  • D3与Dys功能同步降低与精神分裂症患者及小鼠执行功能、工作记忆改善相关。
  • 该交互产生前额叶皮层D2/D3失衡、偏向D2信号增强,纹状体无此变化。
  • 对PANSS评分无上位效应,对感觉运动门控、运动功能及社交行为仅有边缘效应。

核心结论

  • D3与Dys功能遗传变异间存在上位性交互,同步功能降低与执行功能和工作记忆改善相关。
  • 该交互导致前额叶皮层D2/D3失衡、偏向D2信号增强,提示其作为精神分裂症患者分层与促认知治疗靶点。

研究设计与样本

  • 研究纳入精神分裂症患者与基因修饰小鼠,分析Dys与D3功能遗传变异的上位性交互。

主要发现

  • 在精神分裂症患者与基因修饰小鼠中,D3与Dys功能同步降低均与执行功能和工作记忆能力改善相关。
  • D3/Dys交互产生前额叶皮层D2/D3失衡、偏向D2信号增强,纹状体未见此变化。
  • 对PANSS评分无上位效应,小鼠中仅见对感觉运动门控、运动功能及社交行为的边缘效应。

临床怎么用

  • 前额叶皮层D2/D3失衡可作为精神分裂症患者分层与促认知治疗的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The dopamine D2 and D3 receptors are implicated in schizophrenia and its pharmacological treatments. These receptors undergo intracellular trafficking processes that are modulated by dysbindin-1 (Dys). Indeed, Dys variants alter cognitive responses to antipsychotic drugs through D2-mediated mechanisms. However, the mechanism by which Dys might selectively interfere with the D3 receptor subtype is unknown. Here, we revealed an interaction between functional genetic variants altering Dys and D3. Specifically, both in patients with schizophrenia and in genetically modified mice, concomitant reduction in D3 and Dys functionality was associated with improved executive and working memory abilities. This D3/Dys interaction produced a D2/D3 imbalance favoring increased D2 signaling in the prefrontal cortex (PFC) but not in the striatum. No epistatic effects on the clinical positive and negative syndrome scale (PANSS) scores were evident, while only marginal effects on sensorimotor gating, locomotor functions, and social behavior were observed in mice. This genetic interaction between D3 and Dys suggests the D2/D3 imbalance in the PFC as a target for patient stratification and procognitive treatments in schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Leggio GM, Torrisi SA, Mastrogiacomo R, et al. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans. Mol Psychiatry. 2019. PMID: 31492942. doi:10.1038/s41380-019-0511-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。